Zim Misses Male Circumcision Target By 81.1 % Due To COVID-19 in 2020

THE national Voluntary Medical Male Circumcision (VMMC) missed its target of circumcising 412,000 men in 2020 and only managed to circumcise 78,000 due to the COVID-19 pandemic which derailed all circumcision efforts countrywide due to tight restrictions on movement. By Michael Gwarisa Zimbabwe adopted VMMC as one of its main HIV prevention strategies for men in 2008 with studies having shown that the practice can help reduce HIV transmission in men by about 60%. To date, over 2 million men have been circumcised in Zimbabwe since the commencement of the…

Read More

ZNNP+ Launches Five Year Strategic Plan To Enhance Communities Response To HIV

THE Zimbabwe National Network for People Living with HIV (ZNNP+) has launched a strategic plan which is set to guide their work as well as intensify communities capacity to respond to HIV at community level. By Michael Gwarisa Officiating at the strategic plan launch event which also coincided with the annual Candlelight Memorial to honor those who lost their lives due to HIV, deputy minister in the Ministry of Health and Child Care (MoHCC), Dr John Mangwiro said the ZNNP+ strategy would help accelerate government’s plans to boost local production…

Read More

#COVID-19: HIV Virological Suppression Critical During COVID-19 Pandemic Says PEPFAR

THE United States President’s Emergency Plan for AIDS Relief (PEPFAR) says it was critical to ensure the HIV viral load is suppressed under the prevailing global health crisis where majority of health services have been interrupted. By Michael Gwarisa PEAPFAR recently published guidelines to ensure continuous and effective HIV and AIDS treatement and care under the prevailing COVID-19 pandemic. Click HERE To Access PEPFAR Document: According to PEPFAR, evidence on the impact of COVID-19 amongst PLHIV was still scarce and there is currently no direct evidence that people with HIV…

Read More

Abbott To Launch Revolutionary Viral Load Testing Technology In Zim

INTERNATIONAL healthcare firm, Abbott  will soon be rolling out a revolutionary viral load technological breakthrough the m-PIMA HIV-1/2 VL  viral  load point-of-care test in Zimbabwe. The turnaround time is only  70 minutes, hence increasing the chances of initiating more people on Anti retro Viral Therapy (ART) and eliminating new transmissions. By Michael Gwarisa The move is in line with UNAIDS 90-90-90 target,  where 90 percent of all people living with HIV will know their HIV status and another 90 percent of all people with diagnosed HIV infection will receive sustained…

Read More